{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T20:55:14Z","timestamp":1783198514770,"version":"3.54.6"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":5698,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1093\/annonc\/mdh213","type":"journal-article","created":{"date-parts":[[2004,5,19]],"date-time":"2004-05-19T21:18:09Z","timestamp":1085001489000},"page":"853-857","source":"Crossref","is-referenced-by-count":19,"title":["CD40 activation: potential for specific immunotherapy in B-CLL"],"prefix":"10.1016","volume":"15","author":[{"given":"M.","family":"von Bergwelt-Baildon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Maecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Schultze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G.","family":"Gribben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdh213_bb0010","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1200\/JCO.2001.19.8.2165","article-title":"Rituximab dose-escalation trial in chronic lymphocytic leukemia","volume":"19","author":"O\u2019Brien","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh213_bb0015","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1182\/blood.V98.5.1326","article-title":"Rituximab therapy of patients with B-cell chronic lymphocytic leukemia","volume":"98","author":"Huhn","year":"2001","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00282-996-0459-0","article-title":"Graft-versus-host disease and graft-versus-leukemia","volume":"38","author":"Michallet","year":"1996","journal-title":"Hematol Cell Ther"},{"key":"10.1093\/annonc\/mdh213_bb0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/10428190009058499","article-title":"40 ligand in cell pathogenesis and therapy","volume":"37","author":"Schattner","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdh213_bb0030","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0167-5699(91)90135-G","volume":"12","author":"Kantor","year":"1991","journal-title":"A new nomenclature for B cells. Immunol Today"},{"key":"10.1093\/annonc\/mdh213_bb0035","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1749-6632.1995.tb55855.x","article-title":"1 cells and autoimmunity","volume":"764","author":"Murakami","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1093\/annonc\/mdh213_bb0040","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European\u2013American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0045","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V94.11.3658","article-title":"Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells","volume":"94","author":"Burger","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0050","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1182\/blood.V86.11.4382b.bloodjournal86114382b","article-title":"Serum levels of interleukin-10 in B-cell chronic lymphocytic leukemia","volume":"86","author":"Knauf","year":"1995","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0055","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2141.1992.tb04561.x","article-title":"Dormer P. B-cell chronic lymphocytic leukaemia cells express and release transforming growth factor-beta","volume":"80","author":"Kremer","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdh213_bb0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/blood.V67.2.279.279","article-title":"Defective interleukin-2 production and responsiveness by T cells in patients with chronic lymphocytic leukemia of B cell variety","volume":"67","author":"Ayanlar-Batuman","year":"1986","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0065","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.178.5.1567","article-title":"In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39","volume":"178","author":"Foy","year":"1993","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/mdh213_bb0070","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0952-7915(97)80078-7","article-title":"Functions of CD40 on B cells","volume":"9","author":"van Kooten","year":"1997","journal-title":"dendritic cells and other cells. Curr Opin Immunol"},{"key":"10.1093\/annonc\/mdh213_bb0075","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.4049\/jimmunol.151.4.1777","article-title":"Regulation of expression of the ligand for CD40 on T helper lymphocytes","volume":"151","author":"Castle","year":"1993","journal-title":"J Immunol"},{"key":"10.1093\/annonc\/mdh213_bb0080","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1084\/jem.177.4.925","article-title":"Activated T cells induce expression of B7\/BB1 on normal or leukemic B cells through a CD40-dependent signal","volume":"177","author":"Ranheim","year":"1993","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/mdh213_bb0085","doi-asserted-by":"crossref","first-page":"666","DOI":"10.4049\/jimmunol.153.2.666","article-title":"T lymphocyte T cell\u2013B cell-activation molecule\/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7\/BB1) and enhance their costimulatory activity","volume":"153","author":"Yellin","year":"1994","journal-title":"J Immunol"},{"key":"10.1093\/annonc\/mdh213_bb0090","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1146\/annurev.iy.12.040194.004313","article-title":"The CD40 antigen and its ligand","volume":"12","author":"Banchereau","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1093\/annonc\/mdh213_bb0095","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1182\/blood.V99.9.3319","article-title":"Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application","volume":"99","author":"von Bergwelt-Baildon","year":"2002","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0100","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/378620a0","article-title":"40 ligand-transduced co-stimulation of T cells in the development of helper function","volume":"378","author":"van Essen","year":"1995","journal-title":"Nature"},{"key":"10.1093\/annonc\/mdh213_bb0105","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0092-8674(93)90668-G","article-title":"The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome","volume":"72","author":"Aruffo","year":"1993","journal-title":"Cell"},{"key":"10.1093\/annonc\/mdh213_bb0110","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/nm0997-984","article-title":"Acquired CD40-ligand deficiency in chronic lymphocytic leukemia","volume":"3","author":"Cantwell","year":"1997","journal-title":"Nat Med"},{"key":"10.1093\/annonc\/mdh213_bb0115","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/blood.V91.8.2689.2689_2689_2697","article-title":"Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity","volume":"91","author":"Schattner","year":"1998","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0120","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood.V92.3.990","article-title":"Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells","volume":"92","author":"Romano","year":"1998","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0125","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3109\/10428190009148403","article-title":"CD40 ligand-induced apoptosis is Fas-independent in human multiple myeloma cells","volume":"36","author":"Tong","year":"2002","journal-title":"Leukemia Lymphoma"},{"issue":"Suppl","key":"10.1093\/annonc\/mdh213_bb0130","first-page":"636a","article-title":"CD40 activated follicular lymphoma cells are resistant to and can overcome generalized T cell unresponsiveness induced by IL-10 and TGFb1","volume":"86","author":"Schultze","year":"1996","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0135","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1182\/blood.V89.10.3806","article-title":"Autologous tumor infiltrating T cells cytotoxic for follicular lymphoma cells can be expanded in vitro","volume":"89","author":"Schultze","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1182\/blood.V88.1.41.41","article-title":"Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen","volume":"88","author":"Cardoso","year":"1996","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0145","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-2141.1999.01474.x","article-title":"Involvement of the CD27-CD70 co-stimulatory pathway in allogeneic T-cell response to follicular lymphoma cells","volume":"106","author":"Schmitter","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdh213_bb0150","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1182\/blood.V93.6.1992.406k23_1992_2002","article-title":"CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells","volume":"93","author":"Buhmann","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood.V100.1.167","article-title":"T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy","volume":"100","author":"Krackhardt","year":"2002","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0160","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1182\/blood.V88.12.4676.bloodjournal88124676","article-title":"Adenovirus vector infection of chronic lymphocytic leukemia B cells","volume":"88","author":"Cantwell","year":"1996","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0165","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.gt.3300499","article-title":"Efficient adenovirus-mediated gene transduction of normal and leukemic hematopoietic cells","volume":"4","author":"Huang","year":"1997","journal-title":"Gene Ther"},{"key":"10.1093\/annonc\/mdh213_bb0170","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI1472","article-title":"Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells","volume":"101","author":"Kato","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1093\/annonc\/mdh213_bb0175","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood.V100.5.1655.h81702001655_1655_1661","article-title":"Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors","volume":"100","author":"Wendtner","year":"2002","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0180","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1089\/104303401300057360","article-title":"Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes","volume":"12","author":"Takahashi","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1093\/annonc\/mdh213_bb0185","first-page":"3195","article-title":"In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphoma","volume":"62","author":"Briones","year":"2002","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdh213_bb0190","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/104303403764539332","article-title":"Bystander transfer of functional human CD40 ligand from gene-modified fibroblasts to B-chronic lymphocytic leukemia cells","volume":"14","author":"Biagi","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1093\/annonc\/mdh213_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.189.1.1","article-title":"Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon gamma, and IL-10: role of B cells in the maintenance of T cell responses","volume":"189","author":"Schultze","year":"1999","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/mdh213_bb0200","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1182\/blood.V90.5.1927","article-title":"CD40 ligand induces an antileukemia immune response in vivo","volume":"90","author":"Dilloo","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0205","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI119822","article-title":"CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy","volume":"100","author":"Schultze","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1093\/annonc\/mdh213_bb0210","first-page":"71","article-title":"CD40-activated B-cells as antigen presenting cells: from immunobiology to immunotherapy","volume":"3","author":"von Bergwelt-Baildon","year":"2003","journal-title":"Modern Aspects Immunobiol"},{"key":"10.1093\/annonc\/mdh213_bb0215","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1073\/pnas.72.6.2357","article-title":"Recognition of immunoglobulin idiotypes by thymus-derived lymphocytes","volume":"72","author":"Janeway","year":"1975","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1093\/annonc\/mdh213_bb0220","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/eji.1830161110","article-title":"Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules","volume":"16","author":"Bogen","year":"1986","journal-title":"Eur J Immunol"},{"key":"10.1093\/annonc\/mdh213_bb0225","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.4049\/jimmunol.139.8.2825","article-title":"Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits","volume":"139","author":"Campbell","year":"1987","journal-title":"J Immunol"},{"key":"10.1093\/annonc\/mdh213_bb0230","first-page":"5145","article-title":"Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells","volume":"61","author":"Gricks","year":"2001","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdh213_bb0235","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/13928","article-title":"Complete molecular remissions induced by patient-specific vaccination plus granulocyte\u2013monocyte colony-stimulating factor against lymphoma","volume":"5","author":"Bendandi","year":"1999","journal-title":"Nat Med"},{"key":"10.1093\/annonc\/mdh213_bb0240","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/76243","article-title":"Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies","volume":"6","author":"Trojan","year":"2000","journal-title":"Nat Med"},{"key":"10.1093\/annonc\/mdh213_bb0245","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1182\/blood.V98.10.2999","article-title":"Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues","volume":"98","author":"Harig","year":"2001","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0250","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1182\/blood-2002-02-0513","article-title":"Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX","volume":"100","author":"Krackhardt","year":"2002","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh213_bb0255","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1471-4906(01)02015-4","article-title":"From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens","volume":"22","author":"Schultze","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1093\/annonc\/mdh213_bb0260","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1182\/blood.V96.9.2917","article-title":"CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia","volume":"96","author":"Wierda","year":"2000","journal-title":"Blood"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419618351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419618351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/15\/6\/853\/301112\/mdh213.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T13:03:08Z","timestamp":1705150988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419618351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0923753419618351"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdh213","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}